Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
CoreMap, a US-based developer of a cure for atrial fibrillation spun out of University of Vermont, has concurrently completed a $3m series A extension and $20m series B round from undisclosed strategic, institutional, venture and individual investors. CoreMap previously raised an initial $10.5m in series A financing led by Qure Ventures, with participation from The Fund at Hula, in September 2020.
Odaia, a Canada-based commercial insights platform aimed at pharmaceutical firms based on University of Toronto research, has obtained $13.8m in a series A round led by Flint Capital, TechCrunch reported yesterday. Innospark Ventures, Alumni Ventures, Graphite Ventures, BDC Capital, MaRS IAF, StandUp Ventures, Panache Ventures and unnamed existing backers took part in the round. The cash will allow Odaia to build out platform features and to hire additional sales, marketing and customer support staff as it eyes an expansion. Odaia previously pocketed $1.6m in a seed round in September 2019.
Haya Therapeutics, a Switzerland-based developer of RNA therapeutics to treat heart failure advancing research from Lausanne University Hospital (CHUV), has added $5m to its seed round thanks to an extension led by Humboldt Fund, with participation from Broadview Ventures, Apollo Health Ventures, Bernina BioInvest, 4See Ventures, Schroder Adveq and Viva BioInnovator. Haya had raised an initial CHF18m ($20m) in seed financing in May 2021, when Broadview Ventures led a consortium also including Apollo, Bernina, 4See Schroder Adveq and Viva BioInnovator.
LinKinVax, a France-based protein-based vaccine platform developer, closed a €4.35m ($5m) seed round yesterday backed by unnamed existing shareholders and angel investors. LinKinVax is advancing work conducted at Vaccine Research Institute, a joint research institute for University of Paris Est Créteil, Mondor Institute of Biomedical Research and Inserm.
Fazua, a Germany-based electric bike drive system maker, has sold a 20% stake to carmaker Porsche as part of an agreement that gives the corporate an option to wholly acquire Fazua. Financial terms of the deal were not disclosed. Fazua previously raised $3.3m in equity in a 2019 round backed by UVC Partners, the venture capital affiliate of TU Munich’s tech transfer office, UnternehmerTUM. UVC Partners had already backed an $8m round in 2018, $3.2m series B round in 2017 and series A round of undisclosed size in 2013.
